aluates Reports

$ 0.0

Automative

Global GLP-1 Drug Peptide API Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-29D15438

Global GLP 1 Drug Peptide API Market Research Report 2023

BUY CHAPTERS

Global GLP-1 Drug Peptide API Market Research Report 2025

Code: QYRE-Auto-29D15438

Report

April 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CPC Scientific

Novo Nordisk

Teva Pharmaceutical Industries Ltd

JYMedtech

Zhejiang Peptites Biotech

Shengnuo Biotechnology

Suzhou Tianma Pharmaceutical

Sinopep

Hybio Pharmaceutical

WuXi AppTec

GLP-1 Drug Peptide API Market

The global market for GLP-1 Drug Peptide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.

North American market for GLP-1 Drug Peptide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for GLP-1 Drug Peptide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of GLP-1 Drug Peptide API include CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP, WuXi AppTec, HYBIO Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1 Drug Peptide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Drug Peptide API.

The GLP-1 Drug Peptide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Drug Peptide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GLP-1 Drug Peptide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GLP-1 Drug Peptide API Market Report

Report Metric	Details
Report Name	GLP-1 Drug Peptide API Market
by Type	Semaglutide Liraglutide Tilpotide
by Application	Diabetes Obesity Other
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP, WuXi AppTec, HYBIO Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Drug Peptide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of GLP-1 Drug Peptide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of GLP-1 Drug Peptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GLP-1 Drug Peptide API Market report?

Ans: The main players in the GLP-1 Drug Peptide API Market are CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP, WuXi AppTec, HYBIO Pharmaceutical

What are the Application segmentation covered in the GLP-1 Drug Peptide API Market report?

Ans: The Applications covered in the GLP-1 Drug Peptide API Market report are Diabetes, Obesity, Other

What are the Type segmentation covered in the GLP-1 Drug Peptide API Market report?

Ans: The Types covered in the GLP-1 Drug Peptide API Market report are Semaglutide, Liraglutide, Tilpotide

Recommended Reports

GLP-1 Therapeutics

Peptide APIs Market

Antidiabetic APIs

1 GLP-1 Drug Peptide API Market Overview

1.1 Product Definition

1.2 GLP-1 Drug Peptide API by Type

1.2.1 Global GLP-1 Drug Peptide API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Semaglutide

1.2.3 Liraglutide

1.2.4 Tilpotide

1.3 GLP-1 Drug Peptide API by Application

1.3.1 Global GLP-1 Drug Peptide API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Diabetes

1.3.3 Obesity

1.3.4 Other

1.4 Global Market Growth Prospects

1.4.1 Global GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global GLP-1 Drug Peptide API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global GLP-1 Drug Peptide API Production Estimates and Forecasts (2020-2031)

1.4.4 Global GLP-1 Drug Peptide API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global GLP-1 Drug Peptide API Production Market Share by Manufacturers (2020-2025)

2.2 Global GLP-1 Drug Peptide API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of GLP-1 Drug Peptide API, Industry Ranking, 2023 VS 2024

2.4 Global GLP-1 Drug Peptide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global GLP-1 Drug Peptide API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of GLP-1 Drug Peptide API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of GLP-1 Drug Peptide API, Product Offered and Application

2.8 Global Key Manufacturers of GLP-1 Drug Peptide API, Date of Enter into This Industry

2.9 GLP-1 Drug Peptide API Market Competitive Situation and Trends

2.9.1 GLP-1 Drug Peptide API Market Concentration Rate

2.9.2 Global 5 and 10 Largest GLP-1 Drug Peptide API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 GLP-1 Drug Peptide API Production by Region

3.1 Global GLP-1 Drug Peptide API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global GLP-1 Drug Peptide API Production Value by Region (2020-2031)

3.2.1 Global GLP-1 Drug Peptide API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of GLP-1 Drug Peptide API by Region (2026-2031)

3.3 Global GLP-1 Drug Peptide API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global GLP-1 Drug Peptide API Production Volume by Region (2020-2031)

3.4.1 Global GLP-1 Drug Peptide API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of GLP-1 Drug Peptide API by Region (2026-2031)

3.5 Global GLP-1 Drug Peptide API Market Price Analysis by Region (2020-2025)

3.6 Global GLP-1 Drug Peptide API Production and Value, Year-over-Year Growth

3.6.1 North America GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan GLP-1 Drug Peptide API Production Value Estimates and Forecasts (2020-2031)

4 GLP-1 Drug Peptide API Consumption by Region

4.1 Global GLP-1 Drug Peptide API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global GLP-1 Drug Peptide API Consumption by Region (2020-2031)

4.2.1 Global GLP-1 Drug Peptide API Consumption by Region (2020-2025)

4.2.2 Global GLP-1 Drug Peptide API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America GLP-1 Drug Peptide API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe GLP-1 Drug Peptide API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific GLP-1 Drug Peptide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific GLP-1 Drug Peptide API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global GLP-1 Drug Peptide API Production by Type (2020-2031)

5.1.1 Global GLP-1 Drug Peptide API Production by Type (2020-2025)

5.1.2 Global GLP-1 Drug Peptide API Production by Type (2026-2031)

5.1.3 Global GLP-1 Drug Peptide API Production Market Share by Type (2020-2031)

5.2 Global GLP-1 Drug Peptide API Production Value by Type (2020-2031)

5.2.1 Global GLP-1 Drug Peptide API Production Value by Type (2020-2025)

5.2.2 Global GLP-1 Drug Peptide API Production Value by Type (2026-2031)

5.2.3 Global GLP-1 Drug Peptide API Production Value Market Share by Type (2020-2031)

5.3 Global GLP-1 Drug Peptide API Price by Type (2020-2031)

6 Segment by Application

6.1 Global GLP-1 Drug Peptide API Production by Application (2020-2031)

6.1.1 Global GLP-1 Drug Peptide API Production by Application (2020-2025)

6.1.2 Global GLP-1 Drug Peptide API Production by Application (2026-2031)

6.1.3 Global GLP-1 Drug Peptide API Production Market Share by Application (2020-2031)

6.2 Global GLP-1 Drug Peptide API Production Value by Application (2020-2031)

6.2.1 Global GLP-1 Drug Peptide API Production Value by Application (2020-2025)

6.2.2 Global GLP-1 Drug Peptide API Production Value by Application (2026-2031)

6.2.3 Global GLP-1 Drug Peptide API Production Value Market Share by Application (2020-2031)

6.3 Global GLP-1 Drug Peptide API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 CPC Scientific

7.1.1 CPC Scientific GLP-1 Drug Peptide API Company Information

7.1.2 CPC Scientific GLP-1 Drug Peptide API Product Portfolio

7.1.3 CPC Scientific GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 CPC Scientific Main Business and Markets Served

7.1.5 CPC Scientific Recent Developments/Updates

7.2 Novo Nordisk

7.2.1 Novo Nordisk GLP-1 Drug Peptide API Company Information

7.2.2 Novo Nordisk GLP-1 Drug Peptide API Product Portfolio

7.2.3 Novo Nordisk GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Novo Nordisk Main Business and Markets Served

7.2.5 Novo Nordisk Recent Developments/Updates

7.3 Teva Pharmaceutical Industries Ltd

7.3.1 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Company Information

7.3.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product Portfolio

7.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served

7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

7.4 JYMedtech

7.4.1 JYMedtech GLP-1 Drug Peptide API Company Information

7.4.2 JYMedtech GLP-1 Drug Peptide API Product Portfolio

7.4.3 JYMedtech GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 JYMedtech Main Business and Markets Served

7.4.5 JYMedtech Recent Developments/Updates

7.5 Zhejiang Peptites Biotech

7.5.1 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Company Information

7.5.2 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product Portfolio

7.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Zhejiang Peptites Biotech Main Business and Markets Served

7.5.5 Zhejiang Peptites Biotech Recent Developments/Updates

7.6 Shengnuo Biotechnology

7.6.1 Shengnuo Biotechnology GLP-1 Drug Peptide API Company Information

7.6.2 Shengnuo Biotechnology GLP-1 Drug Peptide API Product Portfolio

7.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Shengnuo Biotechnology Main Business and Markets Served

7.6.5 Shengnuo Biotechnology Recent Developments/Updates

7.7 Suzhou Tianma Pharmaceutical

7.7.1 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Company Information

7.7.2 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product Portfolio

7.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Suzhou Tianma Pharmaceutical Main Business and Markets Served

7.7.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates

7.8 SINOPEP

7.8.1 SINOPEP GLP-1 Drug Peptide API Company Information

7.8.2 SINOPEP GLP-1 Drug Peptide API Product Portfolio

7.8.3 SINOPEP GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 SINOPEP Main Business and Markets Served

7.8.5 SINOPEP Recent Developments/Updates

7.9 WuXi AppTec

7.9.1 WuXi AppTec GLP-1 Drug Peptide API Company Information

7.9.2 WuXi AppTec GLP-1 Drug Peptide API Product Portfolio

7.9.3 WuXi AppTec GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 WuXi AppTec Main Business and Markets Served

7.9.5 WuXi AppTec Recent Developments/Updates

7.10 HYBIO Pharmaceutical

7.10.1 HYBIO Pharmaceutical GLP-1 Drug Peptide API Company Information

7.10.2 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product Portfolio

7.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 HYBIO Pharmaceutical Main Business and Markets Served

7.10.5 HYBIO Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 GLP-1 Drug Peptide API Industry Chain Analysis

8.2 GLP-1 Drug Peptide API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 GLP-1 Drug Peptide API Production Mode & Process Analysis

8.4 GLP-1 Drug Peptide API Sales and Marketing

8.4.1 GLP-1 Drug Peptide API Sales Channels

8.4.2 GLP-1 Drug Peptide API Distributors

8.5 GLP-1 Drug Peptide API Customer Analysis

9 GLP-1 Drug Peptide API Market Dynamics

9.1 GLP-1 Drug Peptide API Industry Trends

9.2 GLP-1 Drug Peptide API Market Drivers

9.3 GLP-1 Drug Peptide API Market Challenges

9.4 GLP-1 Drug Peptide API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

CPC Scientific

Novo Nordisk

Teva Pharmaceutical Industries Ltd

JYMedtech

Zhejiang Peptites Biotech

Shengnuo Biotechnology

Suzhou Tianma Pharmaceutical

Sinopep

Hybio Pharmaceutical

WuXi AppTec

List of Tables

Table 1. Global GLP-1 Drug Peptide API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global GLP-1 Drug Peptide API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global GLP-1 Drug Peptide API Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global GLP-1 Drug Peptide API Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global GLP-1 Drug Peptide API Production Market Share by Manufacturers (2020-2025)

Table 6. Global GLP-1 Drug Peptide API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global GLP-1 Drug Peptide API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of GLP-1 Drug Peptide API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in GLP-1 Drug Peptide API as of 2024)

Table 10. Global Market GLP-1 Drug Peptide API Average Price by Manufacturers (US$/Ton) & (2020-2025)

Table 11. Global Key Manufacturers of GLP-1 Drug Peptide API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of GLP-1 Drug Peptide API, Product Offered and Application

Table 13. Global Key Manufacturers of GLP-1 Drug Peptide API, Date of Enter into This Industry

Table 14. Global GLP-1 Drug Peptide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global GLP-1 Drug Peptide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global GLP-1 Drug Peptide API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global GLP-1 Drug Peptide API Production Value Market Share by Region (2020-2025)

Table 19. Global GLP-1 Drug Peptide API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global GLP-1 Drug Peptide API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global GLP-1 Drug Peptide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global GLP-1 Drug Peptide API Production (Tons) by Region (2020-2025)

Table 23. Global GLP-1 Drug Peptide API Production Market Share by Region (2020-2025)

Table 24. Global GLP-1 Drug Peptide API Production (Tons) Forecast by Region (2026-2031)

Table 25. Global GLP-1 Drug Peptide API Production Market Share Forecast by Region (2026-2031)

Table 26. Global GLP-1 Drug Peptide API Market Average Price (US$/Ton) by Region (2020-2025)

Table 27. Global GLP-1 Drug Peptide API Market Average Price (US$/Ton) by Region (2026-2031)

Table 28. Global GLP-1 Drug Peptide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global GLP-1 Drug Peptide API Consumption by Region (2020-2025) & (Tons)

Table 30. Global GLP-1 Drug Peptide API Consumption Market Share by Region (2020-2025)

Table 31. Global GLP-1 Drug Peptide API Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global GLP-1 Drug Peptide API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America GLP-1 Drug Peptide API Consumption by Country (2020-2025) & (Tons)

Table 35. North America GLP-1 Drug Peptide API Consumption by Country (2026-2031) & (Tons)

Table 36. Europe GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe GLP-1 Drug Peptide API Consumption by Country (2020-2025) & (Tons)

Table 38. Europe GLP-1 Drug Peptide API Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific GLP-1 Drug Peptide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific GLP-1 Drug Peptide API Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific GLP-1 Drug Peptide API Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption by Country (2026-2031) & (Tons)

Table 45. Global GLP-1 Drug Peptide API Production (Tons) by Type (2020-2025)

Table 46. Global GLP-1 Drug Peptide API Production (Tons) by Type (2026-2031)

Table 47. Global GLP-1 Drug Peptide API Production Market Share by Type (2020-2025)

Table 48. Global GLP-1 Drug Peptide API Production Market Share by Type (2026-2031)

Table 49. Global GLP-1 Drug Peptide API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global GLP-1 Drug Peptide API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global GLP-1 Drug Peptide API Production Value Market Share by Type (2020-2025)

Table 52. Global GLP-1 Drug Peptide API Production Value Market Share by Type (2026-2031)

Table 53. Global GLP-1 Drug Peptide API Price (US$/Ton) by Type (2020-2025)

Table 54. Global GLP-1 Drug Peptide API Price (US$/Ton) by Type (2026-2031)

Table 55. Global GLP-1 Drug Peptide API Production (Tons) by Application (2020-2025)

Table 56. Global GLP-1 Drug Peptide API Production (Tons) by Application (2026-2031)

Table 57. Global GLP-1 Drug Peptide API Production Market Share by Application (2020-2025)

Table 58. Global GLP-1 Drug Peptide API Production Market Share by Application (2026-2031)

Table 59. Global GLP-1 Drug Peptide API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global GLP-1 Drug Peptide API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global GLP-1 Drug Peptide API Production Value Market Share by Application (2020-2025)

Table 62. Global GLP-1 Drug Peptide API Production Value Market Share by Application (2026-2031)

Table 63. Global GLP-1 Drug Peptide API Price (US$/Ton) by Application (2020-2025)

Table 64. Global GLP-1 Drug Peptide API Price (US$/Ton) by Application (2026-2031)

Table 65. CPC Scientific GLP-1 Drug Peptide API Company Information

Table 66. CPC Scientific GLP-1 Drug Peptide API Specification and Application

Table 67. CPC Scientific GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 68. CPC Scientific Main Business and Markets Served

Table 69. CPC Scientific Recent Developments/Updates

Table 70. Novo Nordisk GLP-1 Drug Peptide API Company Information

Table 71. Novo Nordisk GLP-1 Drug Peptide API Specification and Application

Table 72. Novo Nordisk GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Novo Nordisk Main Business and Markets Served

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Company Information

Table 76. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Specification and Application

Table 77. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Teva Pharmaceutical Industries Ltd Main Business and Markets Served

Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates

Table 80. JYMedtech GLP-1 Drug Peptide API Company Information

Table 81. JYMedtech GLP-1 Drug Peptide API Specification and Application

Table 82. JYMedtech GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. JYMedtech Main Business and Markets Served

Table 84. JYMedtech Recent Developments/Updates

Table 85. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Company Information

Table 86. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Specification and Application

Table 87. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Zhejiang Peptites Biotech Main Business and Markets Served

Table 89. Zhejiang Peptites Biotech Recent Developments/Updates

Table 90. Shengnuo Biotechnology GLP-1 Drug Peptide API Company Information

Table 91. Shengnuo Biotechnology GLP-1 Drug Peptide API Specification and Application

Table 92. Shengnuo Biotechnology GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Shengnuo Biotechnology Main Business and Markets Served

Table 94. Shengnuo Biotechnology Recent Developments/Updates

Table 95. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Company Information

Table 96. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Specification and Application

Table 97. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Suzhou Tianma Pharmaceutical Main Business and Markets Served

Table 99. Suzhou Tianma Pharmaceutical Recent Developments/Updates

Table 100. SINOPEP GLP-1 Drug Peptide API Company Information

Table 101. SINOPEP GLP-1 Drug Peptide API Specification and Application

Table 102. SINOPEP GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. SINOPEP Main Business and Markets Served

Table 104. SINOPEP Recent Developments/Updates

Table 105. WuXi AppTec GLP-1 Drug Peptide API Company Information

Table 106. WuXi AppTec GLP-1 Drug Peptide API Specification and Application

Table 107. WuXi AppTec GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. WuXi AppTec Main Business and Markets Served

Table 109. WuXi AppTec Recent Developments/Updates

Table 110. HYBIO Pharmaceutical GLP-1 Drug Peptide API Company Information

Table 111. HYBIO Pharmaceutical GLP-1 Drug Peptide API Specification and Application

Table 112. HYBIO Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. HYBIO Pharmaceutical Main Business and Markets Served

Table 114. HYBIO Pharmaceutical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. GLP-1 Drug Peptide API Distributors List

Table 118. GLP-1 Drug Peptide API Customers List

Table 119. GLP-1 Drug Peptide API Market Trends

Table 120. GLP-1 Drug Peptide API Market Drivers

Table 121. GLP-1 Drug Peptide API Market Challenges

Table 122. GLP-1 Drug Peptide API Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of GLP-1 Drug Peptide API

Figure 2. Global GLP-1 Drug Peptide API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global GLP-1 Drug Peptide API Market Share by Type: 2024 VS 2031

Figure 4. Semaglutide Product Picture

Figure 5. Liraglutide Product Picture

Figure 6. Tilpotide Product Picture

Figure 7. Global GLP-1 Drug Peptide API Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global GLP-1 Drug Peptide API Market Share by Application: 2024 VS 2031

Figure 9. Diabetes

Figure 10. Obesity

Figure 11. Other

Figure 12. Global GLP-1 Drug Peptide API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global GLP-1 Drug Peptide API Production Value (US$ Million) & (2020-2031)

Figure 14. Global GLP-1 Drug Peptide API Production Capacity (Tons) & (2020-2031)

Figure 15. Global GLP-1 Drug Peptide API Production (Tons) & (2020-2031)

Figure 16. Global GLP-1 Drug Peptide API Average Price (US$/Ton) & (2020-2031)

Figure 17. GLP-1 Drug Peptide API Report Years Considered

Figure 18. GLP-1 Drug Peptide API Production Share by Manufacturers in 2024

Figure 19. Global GLP-1 Drug Peptide API Production Value Share by Manufacturers (2024)

Figure 20. GLP-1 Drug Peptide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by GLP-1 Drug Peptide API Revenue in 2024

Figure 22. Global GLP-1 Drug Peptide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global GLP-1 Drug Peptide API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global GLP-1 Drug Peptide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 25. Global GLP-1 Drug Peptide API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. North America GLP-1 Drug Peptide API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe GLP-1 Drug Peptide API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. China GLP-1 Drug Peptide API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan GLP-1 Drug Peptide API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global GLP-1 Drug Peptide API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 31. Global GLP-1 Drug Peptide API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 33. North America GLP-1 Drug Peptide API Consumption Market Share by Country (2020-2031)

Figure 34. U.S. GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Canada GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 36. Europe GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 37. Europe GLP-1 Drug Peptide API Consumption Market Share by Country (2020-2031)

Figure 38. Germany GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. France GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. U.K. GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Italy GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Russia GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Asia Pacific GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 44. Asia Pacific GLP-1 Drug Peptide API Consumption Market Share by Region (2020-2031)

Figure 45. China GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. Japan GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. South Korea GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. China Taiwan GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. Southeast Asia GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. India GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 52. Latin America, Middle East & Africa GLP-1 Drug Peptide API Consumption Market Share by Country (2020-2031)

Figure 53. Mexico GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Brazil GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. Turkey GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. GCC Countries GLP-1 Drug Peptide API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 57. Global Production Market Share of GLP-1 Drug Peptide API by Type (2020-2031)

Figure 58. Global Production Value Market Share of GLP-1 Drug Peptide API by Type (2020-2031)

Figure 59. Global GLP-1 Drug Peptide API Price (US$/Ton) by Type (2020-2031)

Figure 60. Global Production Market Share of GLP-1 Drug Peptide API by Application (2020-2031)

Figure 61. Global Production Value Market Share of GLP-1 Drug Peptide API by Application (2020-2031)

Figure 62. Global GLP-1 Drug Peptide API Price (US$/Ton) by Application (2020-2031)

Figure 63. GLP-1 Drug Peptide API Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GLP 1 Weight Loss Drug Market Research Report 2024

Global GLP 1 Agonists for Obesity Market Research Report 2024

Global Oral GLP 1 Agonist Market Research Report 2024

Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025

Global GLP 1 Agonist Injection Market Research Report 2024

Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025

Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025

Global GLP 1 Injection Market Research Report 2024

GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 based Therapy Market Research Report 2024

Global Peptide Drugs for Diabetes Market Research Report 2024

GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 Weight Loss Pill Market Research Report 2024

Global GLP 1 Weight Loss Injection Market Research Report 2024

Global GLP 1 Injection Pen Market Research Report 2024

Global GLP 1 Receptor Agonist Drugs Market Research Report 2024

GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024

Global GLP 1RA Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions